Diametric Capital’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,633
Closed -$272K 483
2024
Q2
$272K Hold
9,633
0.15% 197
2024
Q1
$356K Sell
9,633
-3,974
-29% -$149K 0.2% 133
2023
Q4
$559K Sell
13,607
-3,240
-19% -$104K 0.34% 89
2023
Q3
$524K Buy
16,847
+380
+2% +$14.7K 0.22% 143
2023
Q2
$660K Sell
16,467
-3,424
-17% -$140K 0.29% 91
2023
Q1
$821K Sell
19,891
-4,994
-20% -$211K 0.39% 73
2022
Q4
$1.13M Sell
24,885
-4,810
-16% -$166K 0.55% 52
2022
Q3
$882K Sell
29,695
-633
-2% -$17.7K 0.44% 78
2022
Q2
$633K Sell
30,328
-2
-0% -$47 0.47% 56
2022
Q1
$863K Buy
30,330
+968
+3% +$24.6K 0.48% 63
2021
Q4
$868K Buy
29,362
+8,153
+38% +$256K 0.66% 42
2021
Q3
$727K Sell
21,209
-3,748
-15% -$134K 0.57% 51
2021
Q2
$922K Buy
24,957
+8,978
+56% +$262K 0.67% 51
2021
Q1
$498K Buy
15,979
+10,270
+180% +$356K 0.38% 72
2020
Q4
$285K Buy
+5,709
New +$225K 0.23% 114

Other funds holding SMTI

Diametric Capital's SMTI Position: Q3 2024 in Review

Diametric Capital sold out of Sanara MedTech (SMTI) in Q3 2024, closing a stake of 9,633 shares — an estimated $272K sold.

Diametric Capital first reported a position in SMTI in Q4 2020 and held it in 15 quarters. The position peaked at $1.13M in Q4 2022. 44 funds tracked by Wall St. Rank hold SMTI as of Q3 2024.

  • Diametric Capital reported no remaining Sanara MedTech position as of Q3 2024 after selling out during the quarter.
  • Diametric Capital sold 9,633 Sanara MedTech shares in Q3 2024, an estimated $272K.
  • Diametric Capital first reported a position in Sanara MedTech in Q4 2020 and held it in 15 quarters.
  • Diametric Capital's Sanara MedTech position peaked at $1.13M in Q4 2022.
  • 44 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2024.

Based on Diametric Capital's 13F filing for Q3 2024, filed 13 Nov 2024.